Annual Long Term Debt
$2.07 M
-$874.00 K-29.69%
31 December 2023
Summary:
Lineage Cell Therapeutics annual long term debt is currently $2.07 million, with the most recent change of -$874.00 thousand (-29.69%) on 31 December 2023. During the last 3 years, it has fallen by -$470.00 thousand (-18.50%). LCTX annual long term debt is now -58.35% below its all-time high of $4.97 million, reached on 31 December 2015.LCTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$1.61 M
-$223.00 K-12.15%
30 September 2024
Summary:
Lineage Cell Therapeutics quarterly long term debt is currently $1.61 million, with the most recent change of -$223.00 thousand (-12.15%) on 30 September 2024. Over the past year, it has dropped by -$531.00 thousand (-24.77%). LCTX quarterly long term debt is now -73.36% below its all-time high of $6.05 million, reached on 31 March 2016.LCTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LCTX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.7% | -24.8% |
| 3 y3 years | -18.5% | -15.1% |
| 5 y5 years | +5.7% | -61.4% |
LCTX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.7% | +5.0% | -45.2% | +9.1% |
| 5 y | 5 years | -47.5% | +5.7% | -61.4% | +9.1% |
| alltime | all time | -58.4% | -73.4% |
Lineage Cell Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.61 M(-12.1%) |
| June 2024 | - | $1.84 M(-14.7%) |
| Mar 2024 | - | $2.15 M(+4.0%) |
| Dec 2023 | $2.07 M(-29.7%) | $2.07 M(-3.5%) |
| Sept 2023 | - | $2.14 M(-11.3%) |
| June 2023 | - | $2.42 M(-9.6%) |
| Mar 2023 | - | $2.67 M(-9.1%) |
| Dec 2022 | $2.94 M(+49.4%) | $2.94 M(+31.9%) |
| Sept 2022 | - | $2.23 M(+51.0%) |
| June 2022 | - | $1.48 M(-18.2%) |
| Mar 2022 | - | $1.81 M(-8.3%) |
| Dec 2021 | $1.97 M(-22.4%) | $1.97 M(+3.8%) |
| Sept 2021 | - | $1.90 M(-9.3%) |
| June 2021 | - | $2.09 M(-6.6%) |
| Mar 2021 | - | $2.24 M(-11.7%) |
| Dec 2020 | $2.54 M(-35.6%) | $2.54 M(+38.9%) |
| Sept 2020 | - | $1.83 M(-45.2%) |
| June 2020 | - | $3.34 M(-7.1%) |
| Mar 2020 | - | $3.59 M(-8.9%) |
| Dec 2019 | $3.94 M(+101.5%) | $3.94 M(-5.5%) |
| Sept 2019 | - | $4.17 M(+6.5%) |
| June 2019 | - | $3.92 M(-4.9%) |
| Mar 2019 | - | $4.12 M(+110.4%) |
| Dec 2018 | $1.96 M | $1.96 M(+47.1%) |
| Sept 2018 | - | $1.33 M(+29.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $1.03 M(-5.4%) |
| Mar 2018 | - | $1.09 M(-6.8%) |
| Dec 2017 | $1.17 M(-59.0%) | $1.17 M(-10.1%) |
| Sept 2017 | - | $1.30 M(-6.8%) |
| June 2017 | - | $1.40 M(-44.5%) |
| Mar 2017 | - | $2.52 M(-11.7%) |
| Dec 2016 | $2.85 M(-42.7%) | $2.85 M(+11.1%) |
| Sept 2016 | - | $2.56 M(+7.6%) |
| June 2016 | - | $2.38 M(-60.7%) |
| Mar 2016 | - | $6.05 M(+21.8%) |
| Dec 2015 | $4.97 M(+959.7%) | $4.97 M(+14.1%) |
| Sept 2015 | - | $4.36 M(+30.7%) |
| June 2015 | - | $3.33 M(+476.5%) |
| Mar 2015 | - | $578.30 K(+23.3%) |
| Dec 2014 | $469.00 K(>+9900.0%) | $469.00 K(+942.2%) |
| Sept 2014 | - | $45.00 K(-21.7%) |
| June 2014 | - | $57.50 K(>+9900.0%) |
| Dec 2013 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2008 | - | $52.60 K(-97.7%) |
| June 2003 | - | $2.25 M(-2.6%) |
| Mar 2003 | - | $2.31 M(+6.5%) |
| Dec 2002 | $2.17 M(+25.3%) | $2.17 M(+6.2%) |
| Sept 2002 | - | $2.04 M(+5.9%) |
| June 2002 | - | $1.93 M(+5.7%) |
| Mar 2002 | - | $1.82 M(+5.4%) |
| Dec 2001 | $1.73 M | $1.73 M |
FAQ
- What is Lineage Cell Therapeutics annual long term debt?
- What is the all time high annual long term debt for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics annual long term debt year-on-year change?
- What is Lineage Cell Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Lineage Cell Therapeutics?
- What is Lineage Cell Therapeutics quarterly long term debt year-on-year change?
What is Lineage Cell Therapeutics annual long term debt?
The current annual long term debt of LCTX is $2.07 M
What is the all time high annual long term debt for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high annual long term debt is $4.97 M
What is Lineage Cell Therapeutics annual long term debt year-on-year change?
Over the past year, LCTX annual long term debt has changed by -$874.00 K (-29.69%)
What is Lineage Cell Therapeutics quarterly long term debt?
The current quarterly long term debt of LCTX is $1.61 M
What is the all time high quarterly long term debt for Lineage Cell Therapeutics?
Lineage Cell Therapeutics all-time high quarterly long term debt is $6.05 M
What is Lineage Cell Therapeutics quarterly long term debt year-on-year change?
Over the past year, LCTX quarterly long term debt has changed by -$531.00 K (-24.77%)